IRIS
VILLANI, ALESSIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.353
EU - Europa 2.818
NA - Nord America 2.764
SA - Sud America 604
AF - Africa 112
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 3
Totale 10.663
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.656
SG - Singapore 2.327
RU - Federazione Russa 1.669
CN - Cina 971
BR - Brasile 502
IT - Italia 458
HK - Hong Kong 448
VN - Vietnam 213
DE - Germania 177
IN - India 147
NL - Olanda 144
KR - Corea 89
FI - Finlandia 68
GB - Regno Unito 62
FR - Francia 55
CA - Canada 49
AR - Argentina 45
MX - Messico 43
SE - Svezia 38
CI - Costa d'Avorio 32
PL - Polonia 32
BD - Bangladesh 24
ZA - Sudafrica 23
IE - Irlanda 22
UA - Ucraina 21
EC - Ecuador 19
ID - Indonesia 17
IQ - Iraq 15
JP - Giappone 15
TR - Turchia 14
AT - Austria 10
MA - Marocco 10
VE - Venezuela 10
ES - Italia 9
LT - Lituania 9
DZ - Algeria 8
EG - Egitto 8
JO - Giordania 7
PK - Pakistan 7
PY - Paraguay 7
BG - Bulgaria 6
CL - Cile 6
AU - Australia 5
IL - Israele 5
KE - Kenya 5
MY - Malesia 5
PE - Perù 5
RO - Romania 5
UZ - Uzbekistan 5
BE - Belgio 4
CO - Colombia 4
CZ - Repubblica Ceca 4
IR - Iran 4
KZ - Kazakistan 4
OM - Oman 4
TW - Taiwan 4
AE - Emirati Arabi Uniti 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
KG - Kirghizistan 3
PA - Panama 3
TN - Tunisia 3
UY - Uruguay 3
AZ - Azerbaigian 2
CH - Svizzera 2
CM - Camerun 2
CR - Costa Rica 2
DK - Danimarca 2
EE - Estonia 2
GA - Gabon 2
GR - Grecia 2
HN - Honduras 2
HR - Croazia 2
HU - Ungheria 2
KH - Cambogia 2
LB - Libano 2
LV - Lettonia 2
LY - Libia 2
ME - Montenegro 2
ML - Mali 2
MN - Mongolia 2
NG - Nigeria 2
NO - Norvegia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
SD - Sudan 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BS - Bahamas 1
BY - Bielorussia 1
CV - Capo Verde 1
CW - ???statistics.table.value.countryCode.CW??? 1
ET - Etiopia 1
EU - Europa 1
Totale 10.639
Salva come PNG Salva come JPEG
Città #
Singapore 1.136
Hefei 454
Hong Kong 448
Moscow 399
Chandler 321
Santa Clara 276
Ashburn 259
Beijing 234
Dallas 146
Amsterdam 110
Kochi 105
Los Angeles 94
Boston 85
Seoul 85
Lawrence 81
Napoli 76
Millbury 70
Redondo Beach 68
Ho Chi Minh City 64
Naples 55
Buffalo 54
Des Moines 46
São Paulo 41
Hanoi 40
Munich 37
New York 37
Helsinki 36
Rome 35
Milan 33
Wilmington 30
The Dalles 29
Warsaw 25
Nanjing 22
Seattle 22
Falkenstein 21
Washington 21
Mexico City 20
Frankfurt am Main 18
Chicago 16
Düsseldorf 16
Brooklyn 15
Kronberg 15
Lappeenranta 15
Rio de Janeiro 15
Stockholm 15
Dublin 14
Turku 14
Chennai 13
Haiphong 12
Houston 12
London 12
Montreal 12
Ottawa 12
Atlanta 11
Orem 11
Phoenix 11
Poplar 11
Quito 11
Tokyo 11
Brasília 10
Campinas 10
Council Bluffs 10
Fairfield 10
Turin 10
Belo Horizonte 9
Biên Hòa 9
Denver 9
Johannesburg 9
Latina 9
Toronto 9
Cagliari 8
Curitiba 8
Guangzhou 8
Lauterbourg 8
Amman 7
Cairo 7
Da Nang 7
Nuremberg 7
Querétaro 7
Woodbridge 7
Afragola 6
Baghdad 6
Boardman 6
Charlotte 6
Guarulhos 6
Ha Long 6
Portsmouth 6
Princeton 6
Salvador 6
Ankara 5
Bengaluru 5
Carapicuíba 5
Changsha 5
Florence 5
Grammichele 5
Guayaquil 5
Hebei 5
Jakarta 5
Jiaxing 5
Muriaé 5
Totale 5.694
Salva come PNG Salva come JPEG
Nome #
Review of oral minoxidil as treatment of hair disorders: in search of the perfect dose 255
A case of the co-existence of subcorneal pustular dermatosis and pyoderma gangrenosum and a review of the literature 157
Therapeutic update of biologics and small molecules for scalp psoriasis: a systematic review 147
Clinical and dermoscopic features of Spitz nevus by sex, age and anatomical site: a study of 913 Spitz naevi 128
How reflectance confocal microscopy can help diagnose an enigmatic variant of dermatofibroma 118
Psoriasis Features in Patients with Inflammatory Bowel Disease 118
Grover disease in a young woman: report of case. 118
Vismodegib treatment in a HIV positive patient on antiretroviral therapy 116
Cutaneous leucocytoclastic vasculitis during secukinumab treatment 114
Squamous Cell Carcinomas in Two Cases of Nail Lichen Planus: Is There a Real Association? 114
Use of Natural Agents and Agrifood Wastes for the Treatment of Skin Photoaging 113
Leiomyoma of the finger in a patient affected by cutaneous Kaposi's sarcoma 112
Reply to Woltsche N. et al. Managing adverse effects by dose reduction during routine treatment of locally advanced basal cell carcinoma with the hedgehog inhibitor vismodegib: a single center experience 112
Cutaneous Bowen’s disease: An analysis of 182 cases according to age, sex, and anatomical site from an Italian center 110
Advanced basal cell carcinoma treated with vismodegib: impact on the lives of patients and their families 110
Letter to the editor regarding article "Falotico JM, Gu L, Lipner SR. Not just pimple popping: The utility of hybrid telemedicine models beyond acne management amidst the ongoing COVID-19 pandemic. J Cosmet Dermatol. 2022;10.1111/jocd.15256" 109
Psoriasis in a cohort of patients with common variable immunodeficiency 108
Effective and tolerable treatment of advanced basal cell carcinoma with vismodegib despite other malignancies 108
COVID-19 and cutaneous manifestations: A review of the published literature 105
The Role of Teledermatology During the COVID-19 Pandemic: A Narrative Review 104
Oral isotretinoin for acne: a complete overview 104
Neutrophilic dermatosis in pregnancy: An uncommon course 104
Adalimumab, Ustekinumab, and Secukinumab in the Management of Hidradenitis Suppurativa: A Review of the Real-Life Experience 103
Teledermatology for acne during COVID-19: high patients' satisfaction in spite of the emergency 103
Teledermoscopy: a promising tool in pediatric practice 102
Efficacy and safety of sonidegib for the management of basal cell carcinoma: a drug safety evaluation 101
Efficacy and safety of a new topical gel formulation containing retinol encapsulated in glycospheres and hydroxypinacolone retinoate, an antimicrobial peptide, salicylic acid, glycolic acid and niacinamide for the treatment of mild acne: preliminary results of a 2-month prospective study 101
It Is Not as It Seems 100
Dermoscopic patterns of intradermal naevi 100
Dermoscopic assessment of long-term systemic therapy with dupilumab in adult atopic dermatitis 100
Real-Life Effectiveness of Vismodegib in Patients with Metastatic and Advanced Basal Cell Carcinoma: Characterization of Adverse Events and Assessment of Health-Related Quality of Life using the Dermatology Life Quality Index (DLQI) Test 99
Efficacy and safety of vismodegib in patients with basal cell carcinoma: An Italian Center experience 99
Adalimumab versus Rifampicin Plus Clindamycin for the Treatment of Moderate to Severe Hidradenitis Suppurativa: A Retrospective Study 98
Long-Term Efficacy of Vismodegib After its Withdrawal and Patients’ Health-Related Quality of Life Using the Dermatology Life Quality Index (DLQI) 97
Low-Dose Vismodegib as Maintenance Therapy After Locally Advanced Basal Cell Carcinoma Complete Remission: High Efficacy with Minimal Toxicity 97
Patients with bullous disorders during COVID-19 period: Management and adherence to treatment 94
Nail changes as manifestation of systemic disease in COVID‐19 infection 93
Dermatophytid evaluated by in vivo reflectance confocal microscopy: a new approach? 93
Effects of COVID-19 pandemic on malignant melanoma diagnosis 92
Drug safety evaluation of ixekizumab for psoriasis: a review of the current knowledge 90
Teledermatology: a useful tool also after Covid-19 era? 90
Reply to 'Cutaneous adverse effects of the available COVID-19 vaccines in India: A questionnaire-based study' by Bawane J et al 89
Tinea Capitis in Campania: A 5-Year Retrospective Study in Childhood and Adolescence (2013-2018). 89
Efficacy and Safety of Cemiplimab for the Management of Non-Melanoma Skin Cancer: A Drug Safety Evaluation 88
The remarkable increase of squamous cell carcinomas: a retrospective single-center study of 14-years study period 88
Teledermatology for Common Inflammatory Skin Conditions: The Medicine of the Future? 87
Comment on: “Clinical characteristics of patients with pityriasis rubra pilaris following SARS‐CoV‐2 vaccination” by Gambichler 87
Advanced Squamous Cell Carcinoma Developed on Chronic Hidradenitis Suppurativa, Successfully Treated with Cemiplimab: A Case Report 87
Unaddressed Challenges in the Treatment of Cutaneous Melanoma? 86
Assessment of the adverse events related to hedgehog pathway inhibitor therapy for basal cell carcinoma: A single-centre retrospective study 86
The Impact of COVID-19 Vaccination on Inflammatory Skin Disorders and Other Cutaneous Diseases: A Review of the Published Literature 85
Long-term efficacy of telemedicine for patients with locally advanced basal cell carcinoma during COVID-19 pandemic 85
The impact of COVID-19 pandemic on nonmelanoma skin cancers: report of a Southern Italy referral centre 85
Systemic Treatment of Pediatric Psoriasis: A Review. 85
Cutaneous melanoma associated with naevi prevalence: A 15-year cross-sectional retrospective study 85
Teledermatology and chronic skin diseases: real life experience in a Southern Italian Dermatologic Centre 84
Cemiplimab for the treatment of advanced cutaneous squamous cell carcinoma 84
Reflectance confocal microscopy for Kaposi's sarcoma treatment monitoring after intralesional vincristine chemotherapy 84
Efficacy and safety of ustekinumab in a group of 22 elderly patients with psoriasis over a 2-year period 83
Reply to Wong C et al. "Comparison of daily dosing vs. Monday through Friday dosing of vismodegib for locally advanced basal cell carcinoma (laBCC) and basal cell nevus syndrome: a retrospective case series" 81
COVID-19 vaccination and inflammatory skin diseases 81
Reply to ‘Impact of the French COVID ‐19 pandemic lockdown on newly diagnosed melanoma delay and severity’ by R. Molinier et al 80
Adalimumab biosimilar in a pediatric patient: clinical and in vivo reflectance confocal microscopy evaluation 79
Bimekizumab treatment in patients with moderate to severe plaque psoriasis: a drug safety evaluation 78
Teledermatology for acne patients: How to reduce face-to-face visits during COVID-19 pandemic 78
Climate change and the role of dermatologists: a call to action 77
Dermoscopy and reflectance confocal microscopy of Kaposi's sarcoma: an overview 77
Letter to the editor regarding article "Gu L, Diaz SM, Lipner SR. Retrospective study of acne telemedicine and in-person visits at an academic center during the COVID-19 pandemic. J Cosmet Dermatol. 2022;21(1):36-38." 76
Development of a Patient-Reported Outcome Measure (PROM) for Dysgeusia During Treatment With Smoothened (SMO) Inhibitors for Basal Cell Carcinomas: The SMO-iD Questionnaire 75
Dietary intervention in acne management: review of the literature and future prospective 75
The Past, the Present and the Future of Teledermatology: A Narrative Review 74
Complete remission of an advanced basal cell carcinoma after only 3-month treatment with sonidegib: Report of a case and drug management during COVID-19 pandemic 74
Maskne prevalence and risk factors during the COVID-19 pandemic 73
Systemic Treatment of Adult Atopic Dermatitis: A Review 73
Alopecia universalis improvement following risankizumab in a psoriasis patient 73
Telemedicine and support groups could be used to improve adherence to treatment and health-related quality of life in patients affected by inflammatory skin conditions during the COVID-19 pandemic 73
Cutaneous Squamous Cell Carcinoma: From Diagnosis to Follow-Up 72
Author Reply to “Comment on ChatGPT and Medical Writing in Dermatology: why should we keep writing?” by Daungsupawong et al 71
A Case of Recalcitrant Circinate Generalized (Lapière) Psoriasis Successfully Treated with Risankizumab 71
Hedgehog inhibitors in the treatment of advanced basal cell carcinoma: risks and benefits 71
Trends in epidemiology of melanoma in situ in a center of South-Italy: Data from a melanoma reference center during the period 2004–2018 69
Comment on 'Development of Chilblains Lesions During the COVID-19 Pandemic is Strongly Associated with Cold Weather: Retrospective Analysis of Patients from a Single Center in the United States' 68
Herpes Zoster and COVID-19 Vaccination: A Narrative Review 68
Cutaneous adverse reaction following COVID-19 vaccination: Report from a southern Italian referral centre. Comment on "cutaneous adverse reactions following the Pfizer/BioNTech COVID-19 vaccine" by Luo et al 68
Editorial: New strategies for the treatment of advanced melanoma and non-melanoma skin cancer 68
An update on the current and emerging pharmacotherapies for basal cell carcinomas 67
Patient satisfaction with remote dermatology consultations during the COVID-19 pandemic. Comment on 'A qualitative assessment of patient satisfaction with remote dermatology consultations used during the UK's first wave of the COVID-19 pandemic in a single, secondary-care dermatology department' 66
Second primary melanoma: incidence rate and risk factors 66
Comment on: “Second primary melanomas in a cohort of 977 melanoma patients within the first 5 years of monitoring” 65
ChatGPT and Dermatology: friends or foes? 63
Viral Reactivation Following COVID-19 Vaccination: a review of the current literature 63
Letter to the editor regarding article "Hlaca N, Zagar T, Kastelan M, Peternel S, Brajac I, Prpic-Massari L. New-onset lichen planus and lichen planus flare in elderly women after COVID-19 vaccination. J Cosmet Dermatol. 2022;10.1111/jocd.15185" 62
ChatGPT and dermatology 62
Author Reply to “Comment on ChatGPT and Medical Writing in Dermatology: why should we keep writing?” by Duff et al 61
Line-field confocal optical coherence tomography discloses an unexpected traumatic tattoo confirmed by histopathology following a car accident 61
Strategies to Improve Outcomes of Bullous Pemphigoid: A Comprehensive Review of Clinical Presentations, Diagnosis, and Patients' Assessment 61
Resistance to hedgehog inhibitors in basal cell carcinoma: strategies to adopt 61
The effectiveness of vismodegib in patients with advanced periocular basal cell carcinoma: a case series of 13 patients 60
Teledermatology in the management of hidradenitis suppurativa: Should we improve this service? 59
Letter to the editor submitted in response to "psoriasis in pregnancy: case series and literature review of data concerning exposure during pregnancy to ustekinumab" 59
Totale 8.942
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.110
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.110
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021148 0 0 0 0 0 7 2 74 3 50 8 4
2021/2022415 0 0 4 2 2 20 18 18 17 35 99 200
2022/2023765 102 76 19 34 104 68 7 80 115 95 41 24
2023/2024728 28 105 65 37 41 87 10 67 34 28 138 88
2024/20254.138 210 225 31 46 116 250 361 297 281 594 1.396 331
2025/20264.453 822 795 923 671 1.068 174 0 0 0 0 0 0
Totale 10.874